(Q74088128)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10919680%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10919680%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

R Kunka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10919680%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S Andrews

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10919680%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M Pimazzoni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10919680%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S Callejas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10919680%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

L Ziviani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10919680%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

L Squassante

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10919680%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P T Daley-Yates

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10919680%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10919680%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10919680%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

94 Suppl B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10919680%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

S10-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10919680%20AND%20SRC:MED&resulttype=core&format=json

Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2980144-4

7 January 2021

Efficacy of inhaled corticosteroids in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2980144-4

7 January 2021

Effects of inhaled corticosteroids on the consequences of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2980144-4

7 January 2021

Control of asthma by aerosols

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2980144-4

7 January 2021

Metered-dose inhalers and CFCs: what respiratory physicians need to know

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2980144-4

7 January 2021

The continued need for metered dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2980144-4

7 January 2021

Pharmaceutical transition to non-CFC pressurized metered dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2980144-4

7 January 2021

GR106642X: a new, non-ozone depleting propellant for inhalers.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2980144-4

7 January 2021

Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2980144-4

7 January 2021

Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2980144-4

7 January 2021

Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2980144-4

7 January 2021

Structure-activity relationships of topically active steroids: the selection of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2980144-4

7 January 2021

A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2980144-4

7 January 2021

Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2980144-4

7 January 2021

Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2980144-4

7 January 2021

10.1016/S0954-6111(00)80144-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10919680%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference